Presidio Pharmaceuticals Report issue

For profit Phase 1 Phase 2
Founded: San Francisco CA United States (2006)
Status: Acquired by BioCryst (2012)

Organization Overview

First Clinical Trial
2010
NCT01247194
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Presidio Pharmaceuticals, Inc.